Probability in Biological Technology

New Report Just Published: World Prostate Cancer Therapeutics Market Report

... the Risk of Prostate Cancer II-7 Table 4: probability of Developing Invasive Prostate Cancer by Age ... Facts to Gaze at II-20 Table 13: Lifetime probability of Developing Cancer (in Men) by Type in the ... Cancer Therapeutics Market III-1 Table 20: probability of Developing Invasive Prostate Cancer by Age ...

GeneNews reports positive results from validation study of colorectal cancer biomarkers in late-breaking abstract at AACR

... were defined as having a 3-fold increased probability of currently having colorectal cancer. - ... 20% were defined as having an average probability of currently having colorectal cancer. - ... 62% were defined as having a 4-fold decreased probability of currently having colorectal cancer. "There is ...

New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition

... proportions in the population. With pure probability samples, with 100 percent response rates, it is ... is not greater than some number. With a pure probability sample of 400, one could say with a ninety-five percent probability that the overall results would have a sampling ...

A supercharged metal-ion generator

... determine the self-sputtering threshold," Anders explains. "One is the probability that a sputtered atom gets ionized. Another is the probability that the new ion returns to the target. Finally, there's the actual yield ...

AEterna Zentaris Announces Outcome of Management's Strategic Review

... assessment of the value of our assets, our abilities and resources, the probability of success and return on investment potential of each of our product ... highest priority, being the asset with the largest combination of probability of success, proximity to launch and potential medical and commercial ...

Debiopharm and MSM Protein Technologies Sign Agreement for Research and Development of Debio 0929, a Novel Oncology Biologic

... multispanners such as GPCRs in highly concentrated and purified form while retaining their native conformation and orientation thereby maximizing the probability of raising functional antibodies. MSM has demonstrated the ability to raise functional human antibodies against a number of GPCRs and other membrane ...

Varian Medical Systems to Showcase a Wide Spectrum of New and Updated Products That Improve Radiotherapy Treatment Processes at 2009 AAPM Meeting

... models based on clinical data to improve the quality of treatment plans. Biological evaluation , which presents information about the probability of achieving tumor control alongside the risk of damaging healthy tissues for a given treatment plan, so that the most helpful, least harmful ...

American Mothers Seriously Concerned About Childhood Allergies, Siemens Survey Reveals

... associated with significant economic costs, health risks and even morbidity and mortality.(3) "If allergies go untreated, there is a higher probability that the child will develop additional, more severe symptoms, including asthma," said Dr. Terrence Zipfel, allergist and otorhinolaryngologist, East ...

iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming

... iPierian's approach places the patient at the forefront of the drug discovery process, thereby reducing drug development time and increasing the probability of success for drug candidates. iPierian plans to use precise human disease models to find new molecular targets and develop proprietary therapeutic ...

Celtic Pharma Holdings Announces Investment in Novacta Biosystems Limited

... technologies and bringing both funding and additional commercial, regulatory, drug development and manufacturing experience to increase both the probability of success and the value of the products. We are looking forward to working with the dynamic management team at Novacta under Tony Sedgwick, ...

iZumi Bio Appoints Dr. Corey Goodman to Board of Directors and Scientific Advisory Board

... iZumi's approach places the patient at the forefront of the drug discovery process, which could reduce drug development time and increase the probability of success for drug candidates. iZumi plans to use cellular reprogramming, including its iPS technology, to find new molecular targets and develop ...

Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin(R) in Subgroup Analyses from Its Phase 3 Study for the Treatment of CDI

... minimal disruption to the normal intestinal flora. This may facilitate the return of the normal physiological conditions in the colon and reduce the probability of CDI recurrence. About Optimer Pharmaceuticals Optimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, ...

Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting

... disorders. The tests, developed by Power3, are a panel of blood serum protein biomarkers evaluated by biostatistical analysis to predict the probability a patient has neurodegenerative disease. This information will help physicians make earlier diagnoses and recommend appropriate follow-up and ...

Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions

... time. Extended Survival Analysis from MADIT II. Ilan Goldenberg, M.D., will present an analysis from the MADIT II trial of the cumulative probability of all-cause mortality for primary prevention patients at eight years post-implant. The results will be presented at 10:45 a.m. during a ...

iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development

... iZumi's approach places the patient at the forefront of the drug discovery process, which could reduce drug development time and increase the probability of success for drug candidates. iZumi plans to use cellular reprogramming, including its iPS technology, to find new molecular targets and develop ...

Scientists discover 'dancing' algae

... These findings also have implications for clustering of colonies at the air-water interface, where these recirculating flows can enhance the probability of fertilization during the sexual phase of their life cycle. Professor Raymond E. Goldstein, the Schlumberger Professor of Complex Physical ...

Fat droplet nanoparticle delivers tumor suppressor gene to tumor and metastatic cells

... seeing anti-tumor efficacy. Dr. Chang says she is hopeful that the gene therapy will become a first line treatment that will significantly reduce the probability of recurrent tumors. ...

Amniotic Fluid May Provide New Source of Stem Cells for Future Therapies

... the injection and conducting the transplant in adult mice (engraftment is easier to obtain in newborn mice). As additional confirmation of the probability that AFKL cells are indeed stem cells, the researchers examined them for the expression of specific genes known to be involved in hematopoietic ...

Frost & Sullivan European Drug Discovery Product Innovation Award Bestowed on Xenometrix AG

... PAN I cytotoxicity kit allows the application of 4 commonly used cytotoxicity assays sequentially on a cellular sample. Such an approach enhances the probability of identifying toxic compounds, reduces consumption of valuable primary cells, uses lower test compounds than with individual assays and removes ...

The Need for Safe and Affordable Biopharmaceuticals Drives the Development of the European Biosimilars Market, Says Frost & Sullivan

... "As current biosimilars are marketed in the hospital sector, manufacturers must focus their marketing efforts on specialists to increase the probability of success. Moreover, they must make efforts towards advancing physician awareness by disseminating data pertaining to long-term safety and efficacy ...

United Therapeutics Announces Probable Delay in Approval Timeline for Inhaled Treprostinil (Tyvaso)

... and infectious diseases and cancer. Forward-looking Statements Statements included in this press release concerning the probability or likelihood of a delay in the FDA's pending review of our NDA for Tyvaso, the reasons for such delay, the expected duration of such delay and our ...

CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products

... and sterile media products. The use of a cold 4 degrees Celsius fill, as opposed to the normal room temperature fill, significantly increases the probability of maintaining drug activity, potency and thus potentially extending the shelf life of new biological and stem cell produced products. CEL-SCI will ...

ClearTrial Launches Version 2.7 of its Clinical Trial Operations Planning Software Featuring Advanced Portfolio Planning Capability

... creation of portfolios along any clinical development dimension to: Compare portfolios for multiple long-range planning scenarios Assign probability weighting to in-licensing and out-licensing deals Accurately model later-stage studies that are dependent on early study success for more ...

Cleveland Clinic Selects Laparoendoscopic Single-Site Surgery (LESS) as One of the Top Ten Innovations of 2009

... clinical impact (either a major improvement in patient benefit or an improved function that enhances healthcare delivery) Have a high probability of success Be on the market or close to being introduced Have sufficient data available to support its nomination." ...

International Robotic Urology Symposium Reports on Benefits of Cooling During Robotic-Assisted Prostate Surgery and Introduces InnerCool's New Investigational UroCool System

... treatment. While the underlying cause for the development of prostate cancer is still unknown, factors such as age, race, and lifestyle affect the probability of developing the disease. Of these, age is the strongest risk factor, and as life spans continue to increase, more men are surviving to an age at ...

Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study

... treatment. While the underlying cause for the development of prostate cancer is still unknown, factors such as age, race, and lifestyle affect the probability of developing the disease. Of these, age is the strongest risk factor, and as life spans continue to increase, more men are surviving to an age at ...

Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products' Neurodegenerative Diagnostics

... in its CLIA-certified molecular diagnostics laboratory as well as support the tests with development resources. Power3's technology assigns a probability score that reflects how closely a patient's sample fits a biostatistical model for a neurological disease (NuroPro(R)), and indicates if the patient ...

Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries

... treatment. While the underlying cause for the development of prostate cancer is still unknown, factors such as age, race, and lifestyle affect the probability of developing the disease. Of these, age is the strongest risk factor, and as life spans continue to increase, more men are surviving to an age at ...

Prometheus Strengthens Intellectual Property Portfolio with Newly Issued Patents for Thiopurine Metabolite Testing

... PROMETHEUS(R) Thiopurine Metabolites helps keep patients' drug metabolite levels within an optimal therapeutic range, thereby increasing the probability of a positive response and potentially reducing the need for other medications. Thiopurine metabolites testing helps identify some of the reasons for ...

Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use of HemosIL(R) D-Dimer Assay

... (VTE) in outpatients suspected of deep venous thrombosis (DVT) and pulmonary embolism (PE), when used in conjunction with a clinical pretest probability (PTP) assessment model. HemosIL D-Dimer was originally released in 1998, for the quantitative determination of D-Dimer in human citrated plasma and ...

MacroGenics Acquires Raven Biotechnologies

... in development and manufacturing, this transaction should result in the rapid production of new lead therapeutic candidates and increase the probability of clinical and commercial success. Moreover, with the wealth of these assets, we will expand our pursuit of collaborations and other strategic ...

Many paths, few destinations: How stem cells decide what they'll be

... end up in a valley, but which valley it falls into depends on the shape of the landscape. Growth or differentiation factors merely increases the probability that a cell will grow or differentiate, says Donald Ingber, MD, PhD, a co-author on the paper who, with Huang, served as Changs mentor on the ....

Monogram Announces HERmark(TM) Oral Presentation at the 44th ASCO Annual Meeting

... the quantitative measurements of HER2 status provided by HERmark. Patients with higher levels of HER2 and HER2 homodimers correlated with a higher probability of objective response (an endpoint in tumor evaluation) to Herceptin therapy. In addition, those patients with higher HER2 expression levels had a ...

UC San Diego nanostructures will raise thin-film solar cell efficiency

... In the past, engineers have tried to add quantum wells to thin-film solar cell devices by stacking several quantum-well layers to achieve a high probability of absorption of low-energy photons. This approach, however, can be counter productive because electron-hole pairs get stuck in the quantum wells, ...

Vaxgen Files 10-Q for First Quarter With SEC, Provides Future Burn Rate Guidance

... convertible notes. The main reason for the increase in the derivative liability is management's assessment that there is an increased probability of a change of control event, as defined in the indenture related to the notes. * VaxGen's net cash used in operating activities of $4.9 million ...

Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance

... that PCA3 is a useful adjunct to current methods for prostate cancer diagnosis. The researchers found that PCA3 scores correlate with the probability of positive prostate biopsies, and that PCA3 scores are independent of prostate volume, serum PSA level and number of prior biopsies. In the ...

Immune Function in Adult Heart Transplant Patients Reflects Risk for Organ Rejection and Infection

... for Heart and Lung Transplantation (ISHLT) in Boston, MA. "Based on our experience with the ImmuKnow assay we believe it is possible to assess the probability that specific patients are at risk for organ rejection or infection," stated Dr. Kobashigawa. Between 2005 and 2007 Dr. Kobashigawa and his ...

GeneNews announces 2007 year end results

... journal. - Subsequent to year-end on March 14, 2008, received notification that an abstract entitled "Stratification of colorectal cancer probability using six genes from whole blood" was selected for presentation on April 15, 2008 at the annual meeting of the American Association of ...

GeneNews selected to present late-breaking abstract at AACR Annual Meeting

... Sentinel Principle technology." The following GeneNews abstract will be presented: Abstract Number LB-214: "Stratification of colorectal cancer probability using six genes from whole blood." Clinical Research 2, Poster Section 19, Tuesday, April 15, 2008, 8:00 AM About GeneNews -------------- ...

EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study

... over the past 30 years. It is common for more than one tumor to develop in the small intestine and the presence of a carcinoid tumor increases the probability of other cancers in the digestive system. Carcinoid tumors often release certain hormones into the bloodstream that cause symptoms such as facial ...